![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 14
Zeitschriftenartikel
Nack, A.; Brendel, M.; Focke, C.; Deussing, M.; Eckenweber, F.; Sacher, C.; Chrzanowski, U.; Rominger, A. und Kipp, M.
(2017):
[18F]GE180 PET as a sensitive imaging tool to monitor diffuse brain injury.
In: Multiple Sclerosis Journal, Bd. 23: S. 537
Schmutz, S.; Kipp, M.; Nedelcu, J.; Schweiger, F. und Hochstrasser, T.
(2017):
Preferential axonal accumulation of mitochondria during cuprizone-induced demyelination.
In: Multiple Sclerosis Journal, Bd. 23: S. 181
Ertl, C.; Kipp, M.; Engelhardt, M. und Jamann, N.
(2017):
Altered quality and quantity of axon initial segment and nodes of ranvier in different MS mouse models.
In: Multiple Sclerosis Journal, Bd. 23: S. 494
Hochstrasser, T.; Reinbach, C. R.; Pröbstl, N. und Kipp, M.
(2017):
CD44 as a trigger for inflammatory lesion formation.
In: Multiple Sclerosis Journal, Bd. 23: S. 498
Fabisch, K.; Roggenkamp, C.; Hecher, K.; Kipp, M. und Hochstrasser, T.
(2017):
The cuprizone model as a valuable tool to study progressive multiple sclerosis.
In: Multiple Sclerosis Journal, Bd. 23: S. 524
Rohr, S. O.; Ponsaerts, P. und Kipp, M.
(2017):
Innate immune activation is at the root of NMO-like lesion development.
In: Multiple Sclerosis Journal, Bd. 23: S. 769
Chrzanowski, U. und Kipp, M.
(2017):
A new evaluation strategy to measure remyelination in the cuprizone model.
In: Multiple Sclerosis Journal, Bd. 23: S. 772
Behrangi, N.; Kipp, M.; Asl, N. Namvar; Ataei, M.; Dizaji, S.; Javdani, G. und Sanati, M. H.
(2017):
Tart cherry extract as a powerful substance to ameliorate oxidative stress in the cuprizone model.
In: Multiple Sclerosis Journal, Bd. 23: S. 789-790
Draheim, T.; Liessem, A.; Scheld, M.; Wilms, F.; Weißflog, M.; Denecke, B.; Kensler, T. W.; Zendedel, A.; Beyer, C.; Kipp, M.; Wruck, C. J.; Fragoulis, A. und Clarner, T.
(2016):
Activation of the Astrocytic Nrf2/ARE System Ameliorates the Formation of Demyelinating Lesions in a Multiple Sclerosis Animal Model.
In: Glia, Bd. 64, Nr. 12: S. 2219-2230
Hochstrasser, T.; Höflich, K. M. und Kipp, M.
(2016):
Acute axonal damage in three different murine models of multiple sclerosis.
In: Multiple Sclerosis Journal, Bd. 22: S. 163-164
Gottschling, M.; Scheld, M.; Rohr, S.-O.; Clarner, T. und Kipp, M.
(2016):
The transcription factor Ddit3/Chop as a regulator of neuroinflammation.
In: Multiple Sclerosis Journal, Bd. 22: S. 167
Haag, R.; Hochstrasser, T.; Roggenkamp, C.; Kramer, F.; Schmitz, C. und Kipp, M.
(2016):
Signature of neurodegeneration due to primary cytodegeneration and adaptive immune responses.
In: Multiple Sclerosis Journal, Bd. 22: S. 471
Nyamoya, S.; Lanvermann, J.; Dornblut, C.; Morrison, H. und Kipp, M.
(2016):
Signature of neurodegeneration due to primary cytodegeneration and adaptive immune responses.
In: Multiple Sclerosis Journal, Bd. 22: S. 474-475
Roggenkamp, C.; Modlich, M.; Klischies, D.; Kohlschein, C. und Kipp, M.
(2016):
VILIP - an innovative literature research platform.
In: Multiple Sclerosis Journal, Bd. 22: S. 740